You have 9 free searches left this month | for more free features.

Post-transplantation cyclophosphamide

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, MDS Trial in Saint Petersburg (Bendamustine Hydrochloride, Cyclophosphamid)

Recruiting
  • Myeloid Leukemia, Acute
  • +3 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
Apr 4, 2022

GVHD Trial in New York (Bortezomib, Cyclophosphamide)

Active, not recruiting
  • GVHD
  • New York, New York
    New York University School of Medicine
Apr 15, 2022

Hematological Malignancy Trial in Detroit (Bortezomib)

Recruiting
  • Hematological Malignancy
  • Detroit, Michigan
    Henry Ford hospital
Dec 23, 2021

Severe Aplastic Anemia Trial in Atlanta (Fludarabine, Cyclophosphamide, Total Body Irradiation)

Recruiting
  • Severe Aplastic Anemia
  • Atlanta, Georgia
  • +1 more
Apr 4, 2022

Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)

Recruiting
  • Graft Vs Host Disease
  • New York, New York
    NYU Langone Health
Nov 10, 2022

Hematologic Diseases, Graft Failure, Allogeneic Hematopoietic Stem Cell Transplantation Trial (haplo-SCT with PTCy)

Not yet recruiting
  • Hematologic Diseases
  • +2 more
  • haplo-SCT with PTCy
  • (no location specified)
Nov 8, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Trial (Allogenic

Not yet recruiting
  • Refractory Idiopathic Aplastic Anemia
  • Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
  • Allogenic transplantation
  • (no location specified)
Nov 8, 2021

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, Bortezomib)

Recruiting
  • Graft-versus-host Disease
  • New York, New York
    NYU Langone Health
Mar 24, 2022

Acute Leukemia, MDS Trial in Chicago (device, drug, other)

Recruiting
  • Acute Leukemia
  • MDS
  • Arm1
  • Arm 1
  • Chicago, Illinois
    University of Illinois Cancer Center
Oct 13, 2022

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention)

Active, not recruiting
  • Graft-versus-host Disease
  • Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
  • New York, New York
    NYU Langone Health
Aug 5, 2022

Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)

Recruiting
  • Hematological Malignancies
  • Total Body Irradiation
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 4, 2022

GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)

Active, not recruiting
  • Graft Versus Host Disease
  • Hematopoietic/Lymphoid Cancer
  • fludarabine phosphate
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Aug 5, 2022

Acute Myeloid Leukemia Trial in Duarte (procedure, drug, biological, other, radiation)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Jun 8, 2022

Leukemia, Myeloid, Acute, MDS, Myelodysplastic Syndrome Acute Myeloid Leukemia Trial in Denver (Nivolumab)

Withdrawn
  • Leukemia, Myeloid, Acute
  • +2 more
  • Denver, Colorado
    Colorado Blood Cancer Institute
Apr 20, 2021

Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Westwood (EAGD T-cell infusion (Phase

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • EAGD T-cell infusion (Phase I)
  • EAGD T-cell infusion (Expansion)
  • Westwood, Kansas
    University of Kansas Cancer Center
Mar 15, 2022

GVHD, Acute Trial in Shanghai (PT-CY-FK +/-ATG)

Completed
  • GVHD, Acute
  • PT-CY-FK +/-ATG
  • Shanghai, Shanghai, China
    Rui Jin Hospital
May 19, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 1, 2022

Hematopoietic Stem Cell Transplantation Trial in Beijing (post-transplantation cyclophosphamide)

Completed
  • Hematopoietic Stem Cell Transplantation
  • post-transplantation cyclophosphamide
  • Beijing, China
    Peking University People's Hospital
Sep 15, 2020

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Hematopoietic Stem Cell Transplantation Trial (Drug: Cyclophosphamide)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Drug: Cyclophosphamide
  • (no location specified)
Jun 22, 2021

Bone Marrow Transplant Infection, Bone Marrow Transplant Complications, Graft Vs Host Disease Trial in Rozzano (modified donor

Completed
  • Bone Marrow Transplant Infection
  • +4 more
  • modified donor lymphocytes infusion (mDLI)
  • Rozzano, MI, Italy
    Istituto Clinico Humanitas
Dec 24, 2020

Cytomegalovirus Infection After HSCT and PT-CY as GVHD

Completed
  • CMV Infection
    • Malaga, Spain
      Maria Jesus Pascual
    Mar 30, 2022

    Immunodeficiency, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute (NCI) (drug, radiation,

    Recruiting
    • Immunodeficiency
    • Hematopoietic Stem Cell Transplantation
    • Post-Transplant Cyclophosphamide (PTCY)
    • +8 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022